Oxylipin profiling of human plasma reflects the renal dysfunction in uremic patients

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Metabolomics

• Publication date

  2018-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s11306-018-1402-4PMID 30830362
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Combined Inhibition of Soluble Epoxide Hydrolase and Renin-Angiotensin System Exhibits Superior Renoprotection to Renin-Angiotensin System Blockade in 5/6 Nephrectomized Ren-2 Transgenic Hypertensive Rats with Established Chronic Kidney Disease

  2018cited by this paper
• A systematic review on the role of eicosanoid pathways in rheumatoid arthritis.

  2018cited by this paper
• Metabolic profiling of human plasma reveals the activation of 5-lipoxygenase in the acute attack of gouty arthritis

  2018cited by this paper
• Immune-regulation and -functions of eicosanoid lipid mediators

  2017cited by this paper
• Chronic kidney disease and vitamin D metabolism in human bone marrow–derived MSCs

  2017cited by this paper
• Review: Eicosanoids in preterm labor and delivery: Potential roles of exosomes in eicosanoid functions.

  2017cited by this paper
• Drug Metabolism in Kidney Disease

  2017cited by this paper
• Podocyte‐specific soluble epoxide hydrolase deficiency in mice attenuates acute kidney injury

  2017cited by this paper
• Epoxide metabolites of arachidonate and docosahexaenoate function conversely in acute kidney injury involved in GSK3β signaling

  2017cited by this paper
• Effect of aspirin on renal disease progression in patients with type 2 diabetes: A multicenter, double-blind, placebo-controlled, randomized trial. The renaL disEase progression by aspirin in diabetic pAtients (LEDA) trial. Rationale and study design.

  2017cited by this paper
• Cancer Risk and Eicosanoid Production: Interaction between the Protective Effect of Long Chain Omega-3 Polyunsaturated Fatty Acid Intake and Genotype

  2016cited by this paper
• The Effects of CKD on Cytochrome P450-Mediated Drug Metabolism.

  2016cited by this paper
• Assessment of the expression of biomarkers of uremic inflammation in dogs with renal disease.

  2016cited by this paper
• Eicosanoid Mediators in the Airway Inflammation of Asthmatic Patients: What is New?

  2016cited by this paper
• Estimated glomerular filtration rate is unreliable in detecting renal function loss during follow-up after cystectomy and urinary diversion

  2016cited by this paper
• Measuring changes in renal function after bariatric surgery: Why estimated glomerular filtration rate is not good enough.

  2016cited by this paper
• Soluble epoxide hydrolase inhibition ameliorates proteinuria-induced epithelial-mesenchymal transition by regulating the PI3K-Akt-GSK-3β signaling pathway.

  2015cited by this paper
• Impact of soluble epoxide hydrolase inhibition on early kidney damage in hyperglycemic overweight mice.

  2015cited by this paper
• Pharmacological inhibition of soluble epoxide hydrolase prevents renal interstitial fibrogenesis in obstructive nephropathy.

  2015cited by this paper
• The Chronic Kidney Disease-Epidemiology Collaboration (CKD-EPI) equation does not improve the underestimation of Glomerular Filtration Rate (GFR) in people with diabetes and preserved renal function

  2015cited by this paper
• COX-2 is involved in vascular oxidative stress and endothelial dysfunction of renal interlobar arteries from obese Zucker rats.

  2015cited by this paper
• Role of cyclooxygenase-2 in the development of interstitial fibrosis in kidneys following unilateral ureteral obstruction in mice.

  2015cited by this paper
• Intrinsic carnosine metabolism in the human kidney

  2015cited by this paper
• Eicosanoid pathway in colorectal cancer: Recent updates.

  2015cited by this paper
• Estimation of glomerular filtration rate with and without height: effect of age and renal function level

  2015cited by this paper
• Eicosanoid storm in infection and inflammation

  2015cited by this paper
• Persisting eicosanoid pathways in rheumatic diseases

  2014cited by this paper
• Inhibition of soluble epoxide hydrolase prevents renal interstitial fibrosis and inflammation.

  2014cited by this paper
• Discovery of 1-oxa-4,9-diazaspiro[5.5]undecane-based trisubstituted urea derivatives as highly potent soluble epoxide hydrolase inhibitors and orally active drug candidates for treating of chronic kidney diseases.

  2014cited by this paper
• A lipidomic perspective on inflammatory macrophage eicosanoid signaling.

  2014cited by this paper
• Upregulation of soluble epoxide hydrolase in proximal tubular cells mediated proteinuria-induced renal damage.

  2013cited by this paper
• The Obesity-Inflammation-Eicosanoid Axis in Breast Cancer

  2013cited by this paper
• Down-Regulation of Hepatic CYP3A and CYP2C Mediated Metabolism in Rats with Moderate Chronic Kidney Disease

  2012cited by this paper
• Serum oxylipin profiles in IgA nephropathy patients reflect kidney functional alterations

  2012cited by this paper
• Soluble Epoxide Hydrolase Activity Determines the Severity of Ischemia-Reperfusion Injury in Kidney

  2012cited by this paper
• Microsomal Prostaglandin E Synthase 1 Deletion Retards Renal Disease Progression But Exacerbates Anemia in Mice With Renal Mass Reduction

  2012cited by this paper
• Soluble epoxide hydrolase inhibition and peroxisome proliferator activated receptor γ agonist improve vascular function and decrease renal injury in hypertensive obese rats

  2012cited by this paper
• Functional and pathological roles of the 12- and 15-lipoxygenases.

  2011cited by this paper
• Cyclooxygenase 2 promotes parathyroid hyperplasia in ESRD.

  2011cited by this paper
• Diuretics induced uremia and nonrecovery of renal function in a patient with acute renal failure caused by sepsis

  2011cited by this paper
• Inhibition of the Soluble Epoxide Hydrolase Promotes Albuminuria in Mice with Progressive Renal Disease

  2010cited by this paper
• Administration of a substituted adamantyl urea inhibitor of soluble epoxide hydrolase protects the kidney from damage in hypertensive Goto-Kakizaki rats.

  2009cited by this paper
• Role of cytochrome P450 2C8 and 2J2 genotypes in calcineurin inhibitor-induced chronic kidney disease

  2008cited by this paper
• NSAID use and progression of chronic kidney disease.

  2007cited by this paper
• How to measure renal function in clinical practice: Age affects estimated glomerular filtration rate

  2006cited by this paper
• Multiplicity of mammalian reductases for xenobiotic carbonyl compounds.

  2006cited by this paper
• Assessing kidney function--measured and estimated glomerular filtration rate.

  2006cited by this paper
• How to measure renal function in clinical practice: Estimated glomerular filtration rate in general practice

  2006cited by this paper
• Chronic inhibition of NOS-2 ameliorates renal injury, as well as COX-2 and TGF-beta 1 overexpression in 5/6 nephrectomized rats.

  2006cited by this paper
• Key NAD+-binding residues in human 15-hydroxyprostaglandin dehydrogenase.

  2005cited by this paper
• Vascular localization of soluble epoxide hydrolase in the human kidney.

  2004cited by this paper
• Soluble epoxide hydrolase inhibition protects the kidney from hypertension-induced damage.

  2004cited by this paper
• In vitro metabolism of cyclosporine A by human kidney CYP3A5.

  2004cited by this paper
• Cyclooxygenase-2 (COX-2) inhibition limits abnormal COX-2 expression and progressive injury in the remnant kidney.

  2003cited by this paper
• Cyclooxygenase-2 and the kidney: functional and pathophysiological implications.

  2002cited by this paper
• Sympathetic overactivity as a cause of hypertension in chronic renal failure

  2002cited by this paper
• Vitamin E suppresses 5-lipoxygenase-mediated oxidative stress in peripheral blood mononuclear cells of hemodialysis patients regardless of administration route.

  2001cited by this paper
• Identification of the reactive cysteine residue (Cys227) in human carbonyl reductase.

  1999cited by this paper
• The metabolism of 9 alpha-fluorinated steroids in the human kidney.

  1996cited by this paper
• Involvement of two basic residues (Lys-17 and Arg-39) of mouse lung carbonyl reductase in NADP(H)-binding and fatty acid activation: site-directed mutagenesis and kinetic analyses.

  1996cited by this paper
• The metabolism of 9α-fluorinated steroids in the human kidney

  1996cited by this paper
• Cytochrome P450-dependent arachidonic acid metabolism in human kidney.

  1990cited by this paper
• Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach.

  1988cited by this paper

• Time‐of‐Day Defines the Risk of Thermally Abused Frying Oil to Renal Injury by Modulating the Diurnal Dynamics of Oxylipins

  2026cites this paper
• Plasma oxylipin profiling reveals the step-wise activation of ARA/5-HETE metabolism in diabetic kidney disease.

  2025cites this paper
• Plasma metabolomics for the preoperative diagnosis of parathyroid carcinoma

  2025cites this paper
• Metabolomics study reveals blood biomarkers for early diagnosis of chronic kidney disease and IgA nephropathy: A retrospective cross-sectional study.

  2024cites this paper
• Deeper insights into the stability of oxylipins in human plasma across multiple freeze-thaw cycles and storage conditions.

  2024cites this paper
• Oxylipins Derived from PUFAs in Cardiometabolic Diseases: Mechanism of Actions and Possible Nutritional Interactions

  2024cites this paper
• The role of oxylipins and their validation as biomarkers in the clinical context

  2023cites this paper
• Direct targeting of sEH with alisol B alleviated the apoptosis, inflammation, and oxidative stress in cisplatin-induced acute kidney injury

  2023cites this paper
• Cell and rat serum, urine and tissue metabolomics analysis elucidates the key pathway changes associated with chronic nephropathy and reveals the mechanism of action of rhein

  2023cites this paper
• Metabolomics analysis of human plasma reveals decreased production of trimethylamine N‐oxide retards the progression of chronic kidney disease

  2022cites this paper
• Targeted Metabolomics Study of Human Plasma Revealed Activation of the Cytochrome P450 Epoxygenase/Epoxide Hydrolase Axis in Patients with IgA Nephropathy.

  2022cites this paper
• Comparation of oxylipin profiles as well as their substrates and synthetic enzymes transcriptional expression between marine fish Larimichthys crocea and freshwater fish Oncorhynchus mykiss

  2021cites this paper
• NOREVA: enhanced normalization and evaluation of time-course and multi-class metabolomic data

  2020cites this paper
• Effects of hemodialysis on plasma oxylipins

  2020cites this paper
• Oxidized lipids in the metabolic profiling of neuroendocrine tumors - Analytical challenges and biological implications.

  2020cites this paper
• Inhibition of Soluble Epoxide Hydrolase for Renal Health

  2019cites this paper